Current Evidence on Auricular Therapy for Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Systematic Review of Randomized Controlled Trials

Abstract EN

Auricular therapy (AT) has been historically viewed as a convenient approach adjunct to pharmacological therapy for cancer patients with chemotherapy-induced nausea and vomiting (CINV).

The aim of this study was to assess the evidence of the therapeutic effect of AT for CINV management in cancer patients.

Relevant randomized controlled trials were retrieved from 12 electronic databases without language restrictions.

Meanwhile, manual search was conducted for Chinese journals on complementary medicine published within the last five years, and the reference lists of included studies were also checked to identify any possible eligible studies.

Twenty-one studies with 1713 participants were included.

The effect rate of AT for managing acute CINV ranged from 44.44% to 93.33% in the intervention groups and 15% to 91.67% in the control groups.

For delayed CINV, it was 62.96% to 100% and 25% to 100%, respectively.

AT seems to be a promising approach in managing CINV.

However, the level of evidence was low and the definite effect cannot be concluded as there were significant methodological flaws identified in the analyzed studies.

The implications drawn from the 21 studies put some clues for future practice in this area including the need to conduct more rigorously designed randomized controlled trials.